Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

When the idea of looking at cancer center funding and the cancer burden of cancer center catchment areas came to us in the summer of 2024, we lived in a different context. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Todd Burus, PhD
Data scientist, Markey Cancer Center
Caree McAfee, MA, CHES
Administrative director, Operations and Evaluation, Markey Cancer Center
Pamela C. Hull, PhD
Professor, University of Kentucky, Associate director, Population Science and Community Impact, Markey Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

In recent months, several directors of cancer centers, appearing on The Directors, a segment of The Cancer Letter Podcast, mentioned that their institutions are increasingly providing small grants—typically in the range of $50,000—to scientists to enable them to keep their labs open.
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).
Todd Burus, PhD
Data scientist, Markey Cancer Center
Caree McAfee, MA, CHES
Administrative director, Operations and Evaluation, Markey Cancer Center
Pamela C. Hull, PhD
Professor, University of Kentucky, Associate director, Population Science and Community Impact, Markey Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login